19-37127229-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144689.5(ZNF420):c.238G>A(p.Asp80Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,457,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144689.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF420 | NM_144689.5 | c.238G>A | p.Asp80Asn | missense_variant | 5/5 | ENST00000337995.4 | NP_653290.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF420 | ENST00000337995.4 | c.238G>A | p.Asp80Asn | missense_variant | 5/5 | 1 | NM_144689.5 | ENSP00000338770.2 | ||
ENSG00000267360 | ENST00000588873.1 | c.253+28636C>T | intron_variant | 5 | ENSP00000465212.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246686Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133344
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1457358Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 724732
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | The c.238G>A (p.D80N) alteration is located in exon 5 (coding exon 3) of the ZNF420 gene. This alteration results from a G to A substitution at nucleotide position 238, causing the aspartic acid (D) at amino acid position 80 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at